Similar Search Results

Narrow search

Reference pricing of pharmaceuticals for Medicare : evidence from Germany, the Netherlands, and New Zealand

Danzon, Patricia Munch; Ketcham, Jonathan D. - In: Frontiers in health policy research 7 (2004), pp. 1-54

Persistent link: https://www.econbiz.de/10002227583

Direct to the consumer promotion of medication and retail pharmacists : a missing link in the debate

Eagle, Lynne C.; Chamberlain, Kerry; Zou, Liping - 2002

Persistent link: https://www.econbiz.de/10001722271

Reference pricing of pharmaceuticals for medicare : evidence from Germany, the Netherlands and New Zealand

Danzon, Patricia Munch; Ketcham, Jonathan D. - 2003

Persistent link: https://www.econbiz.de/10001806412

Organisations in the public sector : stakeholders, context and PHARMAC

Wynn-Williams, Kate L. H. - In: International journal of public sector management : IJPSM 25 (2012) 5, pp. 346-356

Persistent link: https://www.econbiz.de/10009573272

Ethical and practical implications of pharmaceutical direct-to consumer advertising

Hoek, Janet - In: International journal of nonprofit and voluntary sector … 13 (2008) 1, pp. 73-87

Persistent link: https://www.econbiz.de/10003689803

Does DTC advertising provide information or create market power? Evidence from the US and New Zealand

Taylor, Charles Raymond; Capella, Michael L.; Kozup, John C. - In: Cross-cultural buyer behavior, (pp. 9-30). 2007

Persistent link: https://www.econbiz.de/10003478095

Regulatory oversight or lack of foresight? : Implications for product recall policies and procedures

Eagle, Lynne C.; Rose, Lawrence Craig; Kitchen, Philip J.; … - In: Journal of consumer policy : consumer issues in law, … 28 (2005) 4, pp. 433-460

Persistent link: https://www.econbiz.de/10003240489

Reference Pricing of Pharmaceuticals for Medicare : Evidence from Germany, the Netherlands and New Zealand

Danzon, Patricia Munch - 2003

This paper describes three prototypical systems of therapeutic reference pricing (RP) for pharmaceuticals -- Germany …, manufacturer prices and out-of-pocket surcharges to patients. RP for pharmaceuticals is not simply analogous to a defined …

Persistent link: https://www.econbiz.de/10012468691

Reference Pricing of Pharmaceuticals for Medicare : Evidence from Germany, the Netherlands and New Zealand

Danzon, Patricia M.; Ketcham, Jonathan - 2021

Persistent link: https://www.econbiz.de/10013229388

The rollout of COVID-19 booster vaccines is associated with rising excess mortality in New Zealand

Gibson, John K. - 2022

Persistent link: https://www.econbiz.de/10013270299

A service of the

zbw